These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10678875)

  • 21. Prospective study of hepatitis B vaccination in patients with chronic hepatitis C.
    Wong V; Wreghitt TG; Alexander GJ
    BMJ; 1996 May; 312(7042):1336-7. PubMed ID: 8646046
    [No Abstract]   [Full Text] [Related]  

  • 22. High prevalence of HIV and hepatitis B and C is found among injecting drug users.
    Zarocostas J
    BMJ; 2011 Jun; 342():d4078. PubMed ID: 21712333
    [No Abstract]   [Full Text] [Related]  

  • 23. High compliance with a hepatitis B virus vaccination program among intravenous drug users.
    Mezzelani P; Venturini L; Turrina G; Lugoboni F; Des Jarlais DC
    J Infect Dis; 1991 Apr; 163(4):923. PubMed ID: 1826302
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
    Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
    Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of perceptions of hepatitis B and C status. Value of screening for hepatitis C is still debatable.
    Suckling R; Perrett K; McKendrick M
    BMJ; 2000 Feb; 320(7233):513. PubMed ID: 10722302
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis B vaccine uptake among injecting drug users.
    Lawson J; Holtby I; Eynon C
    J Public Health (Oxf); 2004 Mar; 26(1):116-7. PubMed ID: 15044587
    [No Abstract]   [Full Text] [Related]  

  • 27. Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers.
    Marufu M; Williams H; Hill SL; Tibble J; Verma S
    J Med Virol; 2012 Nov; 84(11):1737-43. PubMed ID: 22997076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Provision of bloodborne virus screening in substance misuse.
    Harniman B
    Nurs Times; 2006 Aug 1-7; 102(31):28-30. PubMed ID: 16913519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatitis B and C risk factors in Germany--results of the national surveillance].
    Walter J; Radun D; Claus H; Hamouda O; Stark K
    Gesundheitswesen; 2005 Jul; 67(7):441-7. PubMed ID: 16103966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B vaccination for injection drug users--Pierce County, Washington, 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 May; 50(19):388-90, 399. PubMed ID: 11465908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands.
    van Houdt R; Sonder GJ; Dukers NH; Bovee LP; van den Hoek A; Coutinho RA; Bruisten SM
    Vaccine; 2007 Mar; 25(14):2698-705. PubMed ID: 16919856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a review.
    Topp L; Day C; Dore GJ; Maher L
    Drug Alcohol Rev; 2009 Nov; 28(6):669-75. PubMed ID: 19930022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.
    Des Jarlais DC; Fisher DG; Newman JC; Trubatch BN; Yancovitz M; Paone D; Perlman D
    Am J Public Health; 2001 Nov; 91(11):1791-2. PubMed ID: 11684603
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements?
    Hope VD; Ncube F; Hickman M; Judd A; Parry JV
    J Viral Hepat; 2007 Sep; 14(9):653-60. PubMed ID: 17697018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suboptimal response to hepatitis B vaccine in drug users.
    Rumi M; Colombo M; Romeo R; Boschini A; Zanetti A; Gringeri A; Mannucci PM
    Arch Intern Med; 1991 Mar; 151(3):574-8. PubMed ID: 1848057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis services at an injecting drug user outreach clinic.
    Moriarty H; Kemp R; Robinson G
    N Z Med J; 2001 Mar; 114(1128):105-6. PubMed ID: 11346154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Working at the sharp end. Interview by Leona Armstrong.
    Kirk W
    Nurs Times; 2002 Dec 10-16; 98(50):44-5. PubMed ID: 12518553
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule.
    Christensen PB; Fisker N; Krarup HB; Liebert E; Jaroslavtsev N; Christensen K; Georgsen J
    Vaccine; 2004 Sep; 22(29-30):3897-901. PubMed ID: 15364437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.